Cargando…
Coronaviruses Lacking Exoribonuclease Activity Are Susceptible to Lethal Mutagenesis: Evidence for Proofreading and Potential Therapeutics
No therapeutics or vaccines currently exist for human coronaviruses (HCoVs). The Severe Acute Respiratory Syndrome-associated coronavirus (SARS-CoV) epidemic in 2002–2003, and the recent emergence of Middle East Respiratory Syndrome coronavirus (MERS-CoV) in April 2012, emphasize the high probabilit...
Autores principales: | Smith, Everett Clinton, Blanc, Hervé, Vignuzzi, Marco, Denison, Mark R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3744431/ https://www.ncbi.nlm.nih.gov/pubmed/23966862 http://dx.doi.org/10.1371/journal.ppat.1003565 |
Ejemplares similares
-
Correction: Coronaviruses Lacking Exoribonuclease Activity Are Susceptible to Lethal Mutagenesis: Evidence for Proofreading and Potential Therapeutics
Publicado: (2014) -
Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is Mediated by the Viral Polymerase and the Proofreading Exoribonuclease
por: Agostini, Maria L., et al.
Publicado: (2018) -
The coronavirus proofreading exoribonuclease mediates extensive viral recombination
por: Gribble, Jennifer, et al.
Publicado: (2021) -
Proofreading-Deficient Coronaviruses Adapt for Increased Fitness over Long-Term Passage without Reversion of Exoribonuclease-Inactivating Mutations
por: Graepel, Kevin W., et al.
Publicado: (2017) -
Structure and dynamics of SARS-CoV-2 proofreading exoribonuclease ExoN
por: Moeller, Nicholas H., et al.
Publicado: (2021)